rs180917336

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_006796.3(AFG3L2):​c.*326G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000219 in 702,316 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00018 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00023 ( 0 hom. )

Consequence

AFG3L2
NM_006796.3 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.44

Publications

0 publications found
Variant links:
Genes affected
AFG3L2 (HGNC:315): (AFG3 like matrix AAA peptidase subunit 2) This gene encodes a protein localized in mitochondria and closely related to paraplegin. The paraplegin gene is responsible for an autosomal recessive form of hereditary spastic paraplegia. This gene is a candidate gene for other hereditary spastic paraplegias or neurodegenerative disorders. [provided by RefSeq, Jul 2008]
TUBB6 (HGNC:20776): (tubulin beta 6 class V) Predicted to enable GTP binding activity. Predicted to be a structural constituent of cytoskeleton. Predicted to be involved in microtubule cytoskeleton organization and mitotic cell cycle. Located in microtubule. [provided by Alliance of Genome Resources, Apr 2022]
TUBB6 Gene-Disease associations (from GenCC):
  • facial palsy, congenital, with ptosis and velopharyngeal dysfunction
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BS1
Variant frequency is greater than expected in population amr. GnomAdExome4 allele frequency = 0.000231 (127/550004) while in subpopulation AMR AF = 0.00245 (85/34692). AF 95% confidence interval is 0.00203. There are 0 homozygotes in GnomAdExome4. There are 60 alleles in the male GnomAdExome4 subpopulation. Median coverage is 0. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006796.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AFG3L2
NM_006796.3
MANE Select
c.*326G>A
3_prime_UTR
Exon 17 of 17NP_006787.2Q9Y4W6
TUBB6
NM_001303525.2
c.*56C>T
3_prime_UTR
Exon 4 of 4NP_001290454.1K7EJ64

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AFG3L2
ENST00000269143.8
TSL:1 MANE Select
c.*326G>A
3_prime_UTR
Exon 17 of 17ENSP00000269143.2Q9Y4W6
TUBB6
ENST00000591909.5
TSL:1
c.*56C>T
3_prime_UTR
Exon 4 of 4ENSP00000465040.1K7EJ64
AFG3L2
ENST00000889396.1
c.*326G>A
3_prime_UTR
Exon 18 of 18ENSP00000559455.1

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152194
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000231
AC:
127
AN:
550004
Hom.:
0
Cov.:
0
AF XY:
0.000201
AC XY:
60
AN XY:
297768
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
15798
American (AMR)
AF:
0.00245
AC:
85
AN:
34692
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20006
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32100
South Asian (SAS)
AF:
0.00
AC:
0
AN:
62714
European-Finnish (FIN)
AF:
0.0000298
AC:
1
AN:
33544
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3698
European-Non Finnish (NFE)
AF:
0.000120
AC:
38
AN:
316890
Other (OTH)
AF:
0.0000982
AC:
3
AN:
30562
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000177
AC:
27
AN:
152312
Hom.:
1
Cov.:
33
AF XY:
0.000148
AC XY:
11
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0000240
AC:
1
AN:
41582
American (AMR)
AF:
0.00124
AC:
19
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000208
Hom.:
0
Bravo
AF:
0.000298
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Spinocerebellar ataxia type 28 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.44
DANN
Benign
0.56
PhyloP100
-1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs180917336; hg19: chr18-12329238; API